2019 BioHealth Capital Region Forum

Top 3 by 2023
Save the Date
April 8+9, 2019 | 1 MedImmune Way
Gaithersburg MD, 20878


20% of the top influencers worldwide in vaccine development


World-class tech + big data + biotech + White House Precision Medicine Initiative = new frontiers in patient-centered medicine


MD | DC | VA

Our Goal: To become a Top 3 BioHealth Hub by 2023.

We are the research engine for the nation and the world. A lifeblood of support for taking new medicines to market. A place where health policymakers and patient advocates seek a better way forward. A home to the established and the startup, pioneering big ideas for human health and hope.

Driving Innovation and Entrepreneurship

  • World–renowned research institutions and universities
  • Influential policymakers and advocacy groups pioneering new health strategies
  • World–leading infectious disease research and vaccine development
  • Fastest growing region for healthcare companies in the U.S.
  • Rated #1 in the nation for science and engineering talent
  • Mission control for the National Cancer Moonshot Initiative

Founding Partners

Banner year: Greater Washington venture capital tops $1.5B in 2017

January 16, 2018

Greater Washington had its second-biggest venture funding year in at least a decade in 2017, with startups across the metro area raking in more than $1.55 billion.

15 companies graduate from UMBC’s bwtech, ready to grow on their own

January 16, 2018

More than 110 companies have graduated since bwtech@UMBC began offering incubation services in 1989.

TAI Diagnostics Raises $10M, Inks Deal With United Therapeutics

January 16, 2018

TAI Diagnostics said earlier this week that it had closed a $10 million round of funding and forged a new partnership with United Therapeutics (NASDAQ: UTHR).

Emergent BioSolutions Initiates Phase 2 Clinical Study to Evaluate FLU-IGIV to Treat Serious Influenza A Infection

January 16, 2018

Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of a Phase 2 dose ranging study to evaluate the safety, pharmacokinetics, and clinical benefit of FLU-IGIV, the company’s anti-influenza immune globulin…

New Money: The 8 D.C. Area Startups That Raised Capital in December

January 16, 2018

In covering the D.C. innovation economy comes the inevitable: funding news. Trust us, there’s a lot of it floating around the D.C. metro area. Here’s a roundup of all of…

Virginia Bio Welcomes New Members to its Board of Directors

January 16, 2018

Virginia Bio, the premier statewide non-profit association representing the life science industry in the Commonwealth of Virginia, has elected two new members to their Board of Directors for a term…